This suggests that abnormal cellular localization of ezrin may lead to the deregulation of several functions in tumor cells that lead to metastasis, including the acquisition of an invasive phenotype and further suggests that a probable post-translational modification of ezrin is taking place as cancer progresses. Here, EZR is linked to cancer.